Cas no 64120-63-4 (4-acetamidobut-2-enoic acid)
4-acetamidobut-2-enoic acid Chemical and Physical Properties
Names and Identifiers
-
- 2-Butenoic acid, 4-(acetylamino)-
- 4-acetamidobut-2-enoic acid
- FGB5PQG5JU
- 4-Acetamido-2-butenoic acid
- 4-Acetamino-2-butenoic acid
- SCHEMBL17438007
- (2E)-4-acetamidobut-2-enoic acid
- AKOS006357195
- SCHEMBL7376039
- EN300-214158
- 64120-63-4
- (E)-4-acetamidobut-2-enoic acid
- 4-Acetamidobut-2-enoicacid
- EN300-3619545
- Q27277975
- UNII-FGB5PQG5JU
-
- MDL: MFCD19219699
- Inchi: 1S/C6H9NO3/c1-5(8)7-4-2-3-6(9)10/h2-3H,4H2,1H3,(H,7,8)(H,9,10)/b3-2+
- InChI Key: FFMCJGYZAHPFJO-NSCUHMNNSA-N
- SMILES: O=C(C)NC/C=C/C(=O)O
Computed Properties
- Exact Mass: 143.05827
- Monoisotopic Mass: 143.058243149g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 10
- Rotatable Bond Count: 3
- Complexity: 162
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 1
- Undefined Bond Stereocenter Count: 0
- XLogP3: -0.6
- Topological Polar Surface Area: 66.4?2
Experimental Properties
- PSA: 66.4
4-acetamidobut-2-enoic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Enamine | EN300-214158-1g |
4-acetamidobut-2-enoic acid |
64120-63-4 | 1g |
$628.0 | 2023-09-16 | ||
| Enamine | EN300-214158-5g |
4-acetamidobut-2-enoic acid |
64120-63-4 | 5g |
$1821.0 | 2023-09-16 | ||
| Enamine | EN300-214158-10g |
4-acetamidobut-2-enoic acid |
64120-63-4 | 10g |
$2701.0 | 2023-09-16 | ||
| Enamine | EN300-214158-0.05g |
4-acetamidobut-2-enoic acid |
64120-63-4 | 0.05g |
$528.0 | 2023-09-16 | ||
| Enamine | EN300-214158-0.1g |
4-acetamidobut-2-enoic acid |
64120-63-4 | 0.1g |
$553.0 | 2023-09-16 | ||
| Enamine | EN300-214158-0.25g |
4-acetamidobut-2-enoic acid |
64120-63-4 | 0.25g |
$579.0 | 2023-09-16 | ||
| Enamine | EN300-214158-0.5g |
4-acetamidobut-2-enoic acid |
64120-63-4 | 0.5g |
$603.0 | 2023-09-16 | ||
| Enamine | EN300-214158-1.0g |
4-acetamidobut-2-enoic acid |
64120-63-4 | 1.0g |
$986.0 | 2023-07-10 | ||
| Enamine | EN300-214158-2.5g |
4-acetamidobut-2-enoic acid |
64120-63-4 | 2.5g |
$1230.0 | 2023-09-16 | ||
| Enamine | EN300-214158-5.0g |
4-acetamidobut-2-enoic acid |
64120-63-4 | 5.0g |
$2858.0 | 2023-07-10 |
4-acetamidobut-2-enoic acid Related Literature
-
Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
-
Patricia A. A. M. Vaz,Jo?o Rocha,Artur M. S. Silva New J. Chem., 2016,40, 8198-8201
-
Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227
-
S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
Additional information on 4-acetamidobut-2-enoic acid
Comprehensive Analysis of 4-Acetamidobut-2-enoic Acid (CAS 64120-63-4): Properties, Applications, and Innovations
4-Acetamidobut-2-enoic acid (CAS 64120-63-4), a versatile organic compound, has garnered significant attention in pharmaceutical and biochemical research due to its unique structural properties. This unsaturated carboxylic acid derivative, characterized by its acetamido and butenoic acid functional groups, serves as a critical intermediate in synthesizing bioactive molecules. Researchers and industries increasingly explore its potential in drug development, particularly for targeting metabolic pathways and inflammation modulation, aligning with current trends in precision medicine and sustainable chemistry.
The compound’s molecular structure (C6H9NO3) features a conjugated double bond, enhancing its reactivity in Michael addition reactions—a hotspot in green chemistry applications. Recent studies highlight its role in designing biodegradable polymers, addressing the global demand for eco-friendly materials. Users frequently search for "4-Acetamidobut-2-enoic acid solubility" or "CAS 64120-63-4 synthesis," reflecting practical concerns in lab-scale production and formulation stability.
In pharmaceuticals, 4-acetamidobut-2-enoic acid derivatives exhibit promise as enzyme inhibitors, particularly in metabolic disorders like diabetes. Its mechanism parallels popular inquiries such as "how to optimize carboxylate bioavailability"—a trending topic in drug delivery systems. Analytical techniques like HPLC and NMR are essential for purity assessment, a recurring question among quality control professionals.
From an industrial perspective, the compound’s compatibility with catalytic hydrogenation aligns with searches for "sustainable catalytic processes." Innovations in flow chemistry have streamlined its production, reducing waste—a key focus in circular economy discussions. Regulatory databases emphasize its safe handling under standard protocols, though it remains non-classified as hazardous.
Emerging applications include its use in peptide mimetics, resonating with the rise of biologics in therapeutics. The compound’s stereochemical flexibility enables chiral synthesis, addressing FAQs like "how to achieve enantioselective reactions." Patent analyses reveal growing IP activity, particularly in oncological and neuroprotective agent development.
Environmental impact assessments confirm its low ecotoxicity, a vital consideration for green manufacturing certifications. As synthetic biology advances, 64120-63-4 derivatives may play a role in bio-based production platforms—answering queries on "alternatives to petrochemical intermediates." Collaborative studies between academia and industry continue to expand its utility, solidifying its position in modern organic chemistry.
64120-63-4 (4-acetamidobut-2-enoic acid) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)